Skip to main content

Crypto Breaking News

Bloomberg
Financial

Agilent CEO on 3Q Earnings, Life Sciences Outlook

Padraig McDonnell, CEO of Agilent Technologies, discussed the company's recent financial performance following a quarter that saw approximately 7% organic revenue growth and an adjusted earnings per share (EPS) of $1.62. The conversation focused on the key drivers behind this growth and the factors contributing to the strong EPS figure. He speaks with Romaine Bostick & Emily Graffeo on "The Close."

Read more: Agilent CEO on 3Q Earnings, Life Sciences Outlook
Bloomberg
Financial

Everpure CEO on Earnings, AI Hyperscaler Impact

Everpure reported a strong quarter with a 38% revenue increase and raised its full-year sales guidance to approximately $600 million. Chairman and CEO Charlie Giancarlo attributed growth to both higher prices and significant market share gains, including a 50% increase in core product sales and a 120% rise in its as-a-service offerings year over year. He speaks with Romaine Bostick & Emily Graffeo on "The Close."

Read more: Everpure CEO on Earnings, AI Hyperscaler Impact
Bloomberg
Financial

RevMed's Pancreatic Cancer Pill Priced Above $475K per Year

Revolution Medicines won US approval for a breakthrough pill that lengthens the lives of patients with advanced pancreatic cancer, a major advance against one of the hardest-to-treat tumor types. The once-daily drug carries a list price of more than $475,000 a year, making it one of the most expensive cancer treatments in history. The company branded it Rasonque and made it available starting Wednesday. It's one of the first medicines to broadly target RAS, a protein tied to tumor growth that's mutated in most pancreatic cancers. The approval opens a new front against a disease where treatment has advanced slowly. Bloomberg's Madison Muller reports.

Read more: RevMed's Pancreatic Cancer Pill Priced Above $475K per Year
Bloomberg
Financial

Investors Looking For Rate Clarity From Warsh Likely Disappointed, Says Jack Manley

Jack Manley, Global Market Strategist at JPMorgan Asset Management, said that he's not expecting to get any information about the path of rates from Fed Chair Kevin Warsh's remarks in Jackson Hole. Manley said that he expects Warsh to paint inflation as the 'be all, end all' for the Fed's economic policy decisions and potentially give insight into how he is measuring that data.

Read more: Investors Looking For Rate Clarity From Warsh Likely Disappointed, Says Jack Manley
Bloomberg
Financial

AI Is 'Accelerant' For Clients, Says S&P Global CFO

Eric Aboaf, CFO of S&P Global, said that his business is to create transparency around hyperscalers for investors as the AI buildout shows no signs of slowing down. Aboaf, who was joined by Bloomberg's Nina Trentmann, said that AI is also an 'accelerant' for S&P Global on the client and revenue side of the business, as feature to help clients access key data.

Read more: AI Is 'Accelerant' For Clients, Says S&P Global CFO
Bloomberg
Financial

Hugging Face Co-Founder on Open-Source Robot, Reports of Nvidia Deal

Hugging Face unveiled MicroDuck, the company's new open-source robot that can walk, talk, and roller-skate. Hugging Face co-founder and Chief Science Officer Thomas Wolf discusses surging demand for robotics and open-source AI, and says the company is currently selling roughly one MicroDuck every four seconds. He also declined to comment on reports that Nvidia is nearing a roughly $13 billion deal to acquire the AI startup, while saying Hugging Face regularly receives acquisition and investment interest. He joins Ed Ludlow on "Bloomberg Tech."

Read more: Hugging Face Co-Founder on Open-Source Robot, Reports of Nvidia Deal
Bloomberg
Financial

Meta Settlement a 'Pittance,' Law Professor Says

Meta's settlement is a "pittance" relative to the company's profits, according to University of Virginia Law Professor Danielle Citron. She argues the bigger question is whether new protections for teenage Facebook and Instagram users will actually work, questioning a framework that relies heavily on parents to enforce limits and warning that teenagers may find ways around the restrictions. She joins Ed Ludlow on "Bloomberg Tech."

Read more: Meta Settlement a 'Pittance,' Law Professor Says
Bloomberg
Financial

US Fighting Affordability War 'On Multiple Fronts' Says Kathryn Edwards

Kathryn Edwards, Bloomberg Opinion columnist and host of the Optimist Economy podcast, said that President Trump's move to lower tariffs on beef imports in an effort to bring prices down is a 'remarkable admission' that tariff policy is increasing prices. Edwards said that the long term cost of beef and other food items is a 'war' the US is 'fighting on multiple fronts' including environmental conditions, industry competition and economic policy.

Read more: US Fighting Affordability War 'On Multiple Fronts' Says Kathryn Edwards